Clinical Trials Directory

Trials / Completed

CompletedNCT02501044

Oxygen Desaturation During Hemodialysis

Oxygen Desaturation During Hemodialysis: Clinical Correlates and Association With Adverse Outcomes

Status
Completed
Phase
Study type
Observational
Enrollment
5,500 (actual)
Sponsor
Renal Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hemodialysis patients may experience drops in blood oxygen saturation during the hemodialysis treatment, which may lead to hypoxia in the tissues. The investigators hypothesize that: 1. The cumulative number, severity, or other characteristics of such deoxygenation episodes may be a predictor of adverse outcomes in hemodialysis patients. 2. There may be demographic, anthropometric, clinical, treatment prescription, lab analytical, and other parameters that correlate with the number and severity of deoxygenation episodes and, therefore, may be used for risk stratification. Further, some of these parameters may be modifiable.

Conditions

Timeline

Start date
2012-01-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2015-07-17
Last updated
2015-07-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02501044. Inclusion in this directory is not an endorsement.

Oxygen Desaturation During Hemodialysis (NCT02501044) · Clinical Trials Directory